Trial on Pulmonary Artery Catheters in Cardiac Surgery Aims to Compare Recovery Outcomes
This clinical trial will evaluate the impact of avoiding pulmonary artery catheters on recovery outcomes in cardiac surgery patients.
Published: June 2, 2026
Updated: June 2, 2026
Author: Humanexa Intelligence
Therapeutic area: Cardiology / Surgical Intervention
Asset: Cardiology
Trial SummaryCLN
Phase III
Cardiology / Surgical Intervention
Status
Active
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Signalmoderate
Confidencemoderate
Why it matters
If successful, this trial could lead to changes in surgical protocols, affecting device manufacturers and healthcare providers focused on cardiac surgery.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results regarding recovery metrics and complication rates, expected in the next 6-12 months.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.